Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
UnitedHealth
UNH
|
+$439M |
| 3 |
Johnson & Johnson
JNJ
|
+$353M |
| 4 |
Amazon
AMZN
|
+$200M |
| 5 |
Microsoft
MSFT
|
+$198M |
Top Sells
| 1 |
EXE
Expand Energy Corporation Common Stock
EXE
|
+$344M |
| 2 |
JPMorgan Chase
JPM
|
+$293M |
| 3 |
Kellanova
K
|
+$165M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$156M |
Sector Composition
| 1 | Technology | 18.85% |
| 2 | Financials | 18.69% |
| 3 | Industrials | 11.91% |
| 4 | Healthcare | 10.42% |
| 5 | Consumer Discretionary | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Peoples Bancorp of North Carolina
PEBK
$169M
| $4.14M | ﹤0.01% |
151,832
-451
| -0.3% | -$12.3K |
|
2552
Navitas Semiconductor
NVTS
$1.3B
| $4.12M | ﹤0.01% |
2,011,376
+618,499
| +44% | +$1.27M |
|
|
IVAC
2553
DELISTED
Intevac Inc
IVAC
| $4.11M | ﹤0.01% |
1,027,992
-17,656
| -2% | -$70.6K |
|
2554
Nexa Resources
NEXA
$645M
| $4.09M | ﹤0.01% |
660,502
+32,088
| +5% | +$199K |
|
2555
Oric Pharmaceuticals
ORIC
$1.05B
| $4.06M | ﹤0.01% |
727,830
+10,642
| +1% | +$59.4K |
|
2556
Fulcrum Therapeutics
FULC
$378M
| $4.05M | ﹤0.01% |
1,407,049
-11,641
| -0.8% | -$33.5K |
|
2557
MaxCyte
MXCT
$158M
| $4.05M | ﹤0.01% |
1,484,357
+55,286
| +4% | +$151K |
|
2558
Princeton Bancorp
BPRN
$221M
| $4.03M | ﹤0.01% |
132,019
+3,487
| +3% | +$107K |
|
2559
Travelzoo
TZOO
$106M
| $3.99M | ﹤0.01% |
292,724
+1,280
| +0.4% | +$17.4K |
|
2560
AMREP Corp
AXR
$118M
| $3.96M | ﹤0.01% |
197,635
+5,677
| +3% | +$114K |
|
2561
First Western Financial
MYFW
$228M
| $3.96M | ﹤0.01% |
201,321
+8,640
| +4% | +$170K |
|
2562
NI Holdings
NODK
$281M
| $3.95M | ﹤0.01% |
277,190
+6,626
| +2% | +$94.5K |
|
2563
Telefônica Brasil
VIV
$19.9B
| $3.95M | ﹤0.01% |
452,621
+27,201
| +6% | +$237K |
|
2564
GCM Grosvenor
GCMG
$684M
| $3.93M | ﹤0.01% |
296,951
+151,538
| +104% | +$2M |
|
|
TBCH
2565
Turtle Beach Corporation Common Stock
TBCH
$300M
| $3.92M | ﹤0.01% |
274,775
-66,091
| -19% | -$943K |
|
2566
Plumas Bancorp
PLBC
$317M
| $3.91M | ﹤0.01% |
90,386
+6,995
| +8% | +$303K |
|
|
AC
2567
DELISTED
Associated Capital Group
AC
| $3.88M | ﹤0.01% |
101,177
-433
| -0.4% | -$16.6K |
|
|
NOAH
2568
Noah Holdings
NOAH
$793M
| $3.87M | ﹤0.01% |
409,031
+17,872
| +5% | +$169K |
|
2569
Oportun Financial
OPRT
$278M
| $3.87M | ﹤0.01% |
705,298
+136,987
| +24% | +$752K |
|
2570
Adtran
ADTN
$849M
| $3.86M | ﹤0.01% |
442,004
-181,931
| -29% | -$1.59M |
|
2571
Aldeyra Therapeutics
ALDX
$334M
| $3.85M | ﹤0.01% |
669,850
-65,913
| -9% | -$379K |
|
2572
Ooma
OOMA
$353M
| $3.85M | ﹤0.01% |
294,451
+8,934
| +3% | +$117K |
|
2573
Rocket Pharmaceuticals
RCKT
$354M
| $3.85M | ﹤0.01% |
577,488
-183,453
| -24% | -$1.22M |
|
|
SAGE
2574
DELISTED
Sage Therapeutics
SAGE
| $3.83M | ﹤0.01% |
481,777
-3,578
| -0.7% | -$28.4K |
|
|
QD
2575
Qudian
QD
$710M
| $3.81M | ﹤0.01% |
1,419,549
+51,842
| +4% | +$139K |
|